Mebuki Financial Group (TSE:7167) Research & Development: 円0 Mil (TTM As of Mar. 2026)


TSE:7167 Mebuki Financial Group Inc TSE:7167
51 GF Score
Price 円1,407.50
GF Value 円924.45
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Mebuki Financial Group Research & Development?

Mebuki Financial Group TSE:7167 +1.96% 51 Research & Development is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:7167 with a GF Score™ of 51/100 and a GF Value™ of 円924.45 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Mebuki Financial Group's Research & Development for the three months ended in Mar. 2026 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was 円0 Mil.

Mebuki Financial Group  (TSE:7167) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Mebuki Financial Group Research & Development Related Terms

Mebuki Financial Group Research & Development Historical Data

* Premium members only.

The historical data trend for Mebuki Financial Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mebuki Financial Group Research & Development Chart

Mebuki Financial Group Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Mebuki Financial Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:7167
51GF Score
Mebuki Financial Group Inc TSE:7167
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mebuki Financial Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
Mebuki Financial Group (TSE:7167) has a Research & Development of 円0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Mebuki Financial Group and its competitors.
Is Mebuki Financial Group's Research & Development too high?
Mebuki Financial Group's current Research & Development is 円0 Mil. Overall, Mebuki Financial Group has a GF Score™ of 51/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mebuki Financial Group's Research & Development compare to competitors?
Mebuki Financial Group's Research & Development of 円0 Mil can be compared against companies in the Banks industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Banks company?
A good Research & Development depends on the Banks industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Mebuki Financial Group and its competitors. Mebuki Financial Group's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mebuki Financial Group stock overvalued right now?
Based on GuruFocus' analysis, Mebuki Financial Group (TSE:7167) is currently considered Significantly Overvalued. The stock's GF Value™ is 円924.45, compared to a current price of 円1,407.50 — trading 52.3% above its estimated fair value. The current Research & Development is 円0 Mil. Mebuki Financial Group's overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Mebuki Financial Group (TSE:7167), the current Research & Development is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mebuki Financial Group (TSE:7167) Overvalued in 2026?

Based on GuruFocus' analysis, Mebuki Financial Group stock appears to be overvalued. The current stock price of 円1,407.50 is trading 52.3% above its estimated GF Value™ of 円924.45. GuruFocus considers Mebuki Financial Group to be Significantly Overvalued.

Key valuation signals for TSE:7167:

  • Research & Development: 円0 Mil
  • GF Value™: 円924.45 vs. price of 円1,407.50 (52.3% above fair value)
  • GF Score™: 51/100 with 5 warning signs

No single metric tells the full story. See the TSE:7167 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mebuki Financial Group Business Description

Other Exchanges MEBUF:USA5EE:Germany
Address 1-25, Sakura 4-chome Utsunomiya, Utsunomiya, Tochigi, JPN, 320-8610
Mebuki Financial Group Inc is a Japan-based company, engages in the provision of banking and other financial services including credit card services in Japan. Its services include loans and bills discounted, deposits, other loans, and assets. It also engages in call money transactions in the short-term markets; and invests in securities primarily comprising bonds, as well as money markets. Its other services include foreign currency exchange and international remittances.
51GF Score

Get the complete analysis for TSE:7167

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,407.50
Price
円924.45
GF Value